CSS
ONC

Cubist Systematic Strategies’s BeOne Medicines Ltd ONC Stock Holding History

Cubist Systematic Strategies’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-108,998
Closed -$29.7M – 3621
2025
Q1 		$29.7M Buy
+108,998
New +$25.5M 0.18% 105
2024
Q4 		– Sell
-13,249
Closed -$2.97M – 3666
2024
Q3 		$2.97M Buy
+13,249
New +$2.38M 0.02% 1186
2024
Q1 		– Sell
-30,096
Closed -$5.43M – 4371
2023
Q4 		$5.43M Buy
+30,096
New +$5.44M 0.04% 818
2023
Q2 		– Sell
-18,079
Closed -$3.9M – 4414
2023
Q1 		$3.9M Buy
18,079
+14,828
+456% +$3.56M 0.02% 1126
2022
Q4 		$715K Buy
+3,251
New +$596K ﹤0.01% 2738
2022
Q3 		– Sell
-7,489
Closed -$1.21M – 4790
2022
Q2 		$1.21M Buy
7,489
+5,257
+236% +$821K 0.01% 2317
2022
Q1 		$421K Buy
+2,232
New +$475K ﹤0.01% 2645
2021
Q3 		– Sell
-16,520
Closed -$5.67M – 3218
2021
Q2 		$5.67M Buy
16,520
+14,909
+925% +$4.94M 0.06% 464
2021
Q1 		$561K Sell
1,611
-21,212
-93% -$7.02M 0.01% 1893
2020
Q4 		$5.9M Buy
+22,823
New +$6.28M 0.08% 371
2020
Q3 		– Sell
-2,493
Closed -$470K – 2672
2020
Q2 		$470K Sell
2,493
-432
-15% -$70.3K 0.01% 1617
2020
Q1 		$360K Sell
2,925
-22,820
-89% -$3.57M 0.01% 1425
2019
Q4 		$4.27M Buy
+25,745
New +$4.28M 0.08% 368
2019
Q2 		– Sell
-4,019
Closed -$531K – 2606
2019
Q1 		$531K Buy
+4,019
New +$542K 0.02% 1156
2018
Q3 		– Sell
-10,388
Closed -$1.6M – 2118
2018
Q2 		$1.6M Buy
10,388
+9,862
+1,875% +$1.76M 0.08% 313
2018
Q1 		$88K Buy
+526
New +$71.2K 0.01% 1612

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cubist Systematic Strategies's ONC Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 108,998 shares — an estimated $29.7M sold.

Cubist Systematic Strategies first reported a position in ONC in Q1 2018 and held it in 16 quarters. The position peaked at $29.7M in Q1 2025. 244 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 108,998 BeOne Medicines Ltd shares in Q2 2025, an estimated $29.7M.
  • Cubist Systematic Strategies first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 16 quarters.
  • Cubist Systematic Strategies's BeOne Medicines Ltd position peaked at $29.7M in Q1 2025.
  • 244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.